Phase I study of LY573636-sodium, an acylsulfonamide anti-cancer compound with a novel mechanism of action, administered as 2-hour IV infusion in patients with advanced solid tumors Meeting Abstract
| Authors: | Ilaria, R. L. Jr; Simon, G. R.; Sovak, M.; Burton, M. K.; Cleverly, A. L.; Sykes, A. K.; De Alwis, D. P.; Wagner, M. M.; Spriggs, D. R. |
| Abstract Title: | Phase I study of LY573636-sodium, an acylsulfonamide anti-cancer compound with a novel mechanism of action, administered as 2-hour IV infusion in patients with advanced solid tumors |
| Meeting Title: | 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 25 |
| Issue: | 18 Suppl. |
| Meeting Dates: | 2007 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2007-06-20 |
| Start Page: | 100s |
| Language: | English |
| ACCESSION: | WOS:000455043700410 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2007.25.18_suppl.2515 |
| Notes: | Meeting Abstract: 2515 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
